AI assistant
Sending…
Climb Bio, Inc. — Director's Dealing 2024
Jun 28, 2024
33982_dirs_2024-06-27_c72b918f-931e-48ff-9703-95db06720c6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Eliem Therapeutics, Inc. (ELYM)
CIK: 0001768446
Period of Report: 2024-06-27
Reporting Person: Brennan Aoife (N/A)
More from Climb Bio, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
Apr 28
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17